Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine

被引：39
|
作者：
Christie, S
Göbel, H
Mateos, V
Allen, C
Vrijens, F
Shivaprakash, M
机构：
[1] Merck & Co Inc, Dept WS3C 90, Whitehouse Stn, NJ 08889 USA
[2] Ottawa Headache Ctr, Ottawa, ON, Canada
[3] Univ Kiel, Kiel Pain Clin, Kiel, Germany
[4] Ctr Hosp Asturias, Dept Neurol, Oviedo, Spain
[5] Merck Sharp & Dohme Europe, Brussels, Belgium
来源：
EUROPEAN NEUROLOGY | 2003年 / 49卷 / 01期
关键词：
rizatriptan; ergotamine; efficacy; preference; migraine;
D O I：
10.1159/000067018
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：20 / 29
页数：10
相关论文
共 50 条
  • [1] Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine
    Goldstein, J
    Ryan, R
    Jiang, KH
    Getson, A
    Norman, B
    Block, GA
    Lines, C
    HEADACHE, 1998, 38 (10): : 737 - 747
  • [2] Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine
    Pascual, J
    Bussone, G
    Hernandez, JF
    Allen, C
    Vrijens, F
    Patel, K
    EUROPEAN NEUROLOGY, 2001, 45 (04) : 275 - 283
  • [3] Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine
    Loder, E
    Brandes, JL
    Silberstein, S
    Skobieranda, F
    Bohidar, N
    Wang, LX
    Boyle, D
    Kolodny, A
    Guerra, F
    Santanello, N
    Johnson-Pratt, L
    HEADACHE, 2001, 41 (08): : 745 - 753
  • [4] Efficacy of rizatriptan 10 mg administered early in a migraine attack
    Cady, Roger
    Martin, Vincent
    Mauskop, Alexander
    Rodgers, Anthony
    Hustad, Carolyn M.
    Ramsey, Karen E.
    Skobieranda, Franck
    HEADACHE, 2006, 46 (06): : 914 - 924
  • [5] Preference for rizatriptan 10-mg wafer versus eletriptan 40-mg tablet for acute treatment of migraine
    Lainez, MJ
    Evers, S
    Allais, G
    Kinge, E
    Allen, C
    Rao, N
    Massaad, R
    Lis, K
    HEADACHE, 2005, 45 (06): : 807 - 808
  • [6] Preference for rizatriptan 10-mg wafer versus eletriptan 40-mg tablet for acute treatment of migraine
    Lainez, MJA
    Evers, S
    Kinge, E
    Allais, G
    Allen, C
    Rao, NA
    Rachid, M
    Lis, K
    CEPHALALGIA, 2005, 25 (10) : 923 - 924
  • [7] A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine
    Carl Dahlöf
    Martin Jones
    Kim Davis
    Jane Loftus
    Reijo Salonen
    The Journal of Headache and Pain, 2004, 5 (2) : 115 - 122
  • [8] Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine
    Bomhof, M
    Paz, J
    Legg, N
    Allen, C
    Vandormael, K
    Patel, K
    EUROPEAN NEUROLOGY, 1999, 42 (03) : 173 - 179
  • [9] Two-period crossover comparison of rizatriptan 5 mg and 10 mg to sumatriptan 25 mg and 50 mg for the acute treatment of migraine
    Norman, BA
    Block, GA
    Jiang, K
    Ahrens, S
    NEUROLOGY, 1998, 50 (04) : A341 - A341
  • [10] Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine:: Analysis of return to function and patient preference
    Pascual, J
    García-Moncó, C
    Roig, C
    Izquierdo, AY
    López-Gil, A
    HEADACHE, 2005, 45 (09): : 1140 - 1150
12345